ZA07 (Divalproex Sodium Delayed-Release 250 mg)

Pill imprint ZA07 has been identified as Divalproex sodium delayed-release 250 mg.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Divalproex sodium delayed-release

Imprint:

ZA07

Strength:

250 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Manufacturer:

Zydus Pharmaceuticals

National Drug Code (NDC):

68382-0032

Inactive Ingredients:

hypromelloses
magnesium stearate
methacrylic acid
polyethylene glycol
silicon dioxide
triethyl citrate
sodium starch glycolate type A potato
povidone
magnesium silicate
microcrystalline cellulose
corn starch

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.